The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
FDA issues draft guidance on nonproprietary naming of biologics, biosimilars
FDA officials recently announced the availability of draft guidance on the nonproprietary naming of biological products, calling it a key issue for ensuring their safety and promoting their acceptance.
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.